| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Senti Biosciences Holdings, Inc.
13D/A
SNTI · 816944102
|
54.6% |
9/11/2026
Event 9/3/2026
|
||||
| Celadon Partners SPV 24 | 54.6% | |||||
| Celadon Partners, LLC | 54.6% | |||||
| CPIF II-7 Limited | 54.6% | |||||
|
Senti Biosciences, Inc.
13D/A
SNTI · 81726A209
|
45.0% |
1/20/2026
Event 1/19/2026
|
||||
| Celadon Partners SPV 24 | 45.0% | |||||
| Celadon Partners, LLC | 45.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.